Category Archives: JPND News

JPND will be represented at the Conference Exhibition on Thursday and Friday, March 8th-9th. Call over to stand S13!

The 27th International Conference of Alzheimer’s Disease International is being held in London from 7 to 10 March 2012. 

Hosted by Alzheimer’s Disease International (ADI) and the Alzheimer’s Society, the conference is conceived as ‘three conferences in one’, under the theme Science, Fact, Fiction.

The conference will be valuable for professionals, scientists, researchers, policy makers, people living with dementia, informal and professional carers.

JPND will be represented at the Conference Exhibition on Thursday and Friday, March 8-9.  Call over to stand S13 to find out more about JPND!

For more details on the Alzheimer International Conference 2012, click on the link below.

Videos of presentations and panel discussions from the Brussels launch of the JPND research strategy on February 7th, 2012 are available on the JPND Youtube channel

To access the video recordings click on the link below:

For other outputs from the launch, including copies of presentations, speeches, photos, press coverage, click on the link below.

JPND has conducted an exercise to map national and European research and infrastructure relevant to neurodegenerative diseases. Interested parties can now search for relevant activities and information on the JPND mapping database

The JPND mapping exercise aims to give an objective view of the scale and scope of research activity in neurodegenerative diseases amongst JPND member countries. The collated information was used to identify gaps and opportunities JPND could build upon and clarify medium to long-term research needs, objectives and priorities. The data collected also provides a baseline for monitoring spend on neurodegenerative disease research activity and resources relevant to neurodegenerative diseases across Europe.

The secondary aim of the JPND mapping exercise was to provide an updateable, publically accessible, database as a resource for the scientific community and other interested parties. The resource is available through the JPND websitehere or by clicking the second link below.

Prevention, independent living, care and cure: are the main areas that the pilot European Innovation Partnership sees as being crucial to extending healthy and active life in Europe.

The Steering Group of the first initiative of the European Commission’sInnovation Union Flagship have agreed on a series of immediate actions to improve active and healthy aging. Philippe Amouyel, Chair of the JPND is a member of the Steering Group and has lead aworkshop on research mapping. Karine Baudin (INSERM Transfert) is a member of the Sherpa Group.

The target is that by 2020, the number of healthy life years in the EU will have increased on average by two years. To reach this target, the partnership wishes to enhance early diagnosis methods; remote monitoring; independent living solutions enabled by information technology; the construction of age-friendly environments; as well as health literacy and personalised health management.

The partnership’s Steering Group is made up of representatives of national governments, hospitals, companies and civil organisations. The European Commission will call for active commitment from Member States, regions and other stakeholders to further expand the range of participants and implement the prioritized actions.

Link toEuropean Commission andFrench Ministry Press Releases on the Innovation Partnership’s action areas.

Professor Philippe Amouyel will present JPND at the first “European Day of the Brain – Ageing, Stroke and Alzheimer’s Disease – Finding Innovative Solutions” on November 18th in Warsaw, Poland.

The meeting is organised by the European Brain Council, together with the Polish Ministry for Health and DG SANCO, to co-incide with the Polish Presidency of the Council of the European Union (July-December 2011).

The event will be attended and addressed by European Parliament President Jerzy Buzek, together with representatives of the European Commission and Polish Government.

More details of the meeting are available at the link below.

Professor Amouyel also presented JPND at the Annual Joint Programming event entitled "Public-to-Public Partnerships", in Brussels on Nov 9-10th, 2011.

More details from this meeting can be found at the link below:

Irish Minister for Research and Innovation welcomes the JPND Mangement Board

The Irish Minister for Research and Innovation, Sean Sherlock TD, extended a warm welcome to the JPND Management Board at its 9th meeting which took place in Dublin Castle on 29 September.

Excerpts from the text of the the Minister’s speech are available by clicking on the link below:

Photographs from the event are available at the link below:

Eight new international research projects have been funded by the JPND-endorsed COEN initiative

The Centres of Excellence in Neurodegeneration Research (CoEN) -initiative, an international funding partnership, has announced investment in eight exciting new international research projects which will address key issues in neurodegenerative disease research.

The CoEN initiative, launched in 2010, funds highly innovative research in the field of neurodegenerative diseases such as dementias and Parkinson’s disease. Under a call for proposals for collaborative research that will serve to underpin future studies, €3.7m  has been awarded to eight new projects spanning the development of new disease models, the identification of biomarkers and the harmonisation of methodologies for clinical studies. These projects bring together a wealth of resources and expertise from a number of large research institutes in different countries to tackle scientific questions that are key to the advancement within the field. 

For further information on the funded projects clickhere or visit:http://coen.org/home.html

JPND would like views on the research priorities identified to date

Following the successful final workshop on its Strategic Reseach Agenda, JPND has launched an online consultation on the research priorities identified to date. 

The consultation is aweb-based survey based on the outcomes from the June meeting and is open for views until Sunday 18th September, 2011. JPND regrets that responses will not be accepted after this date.

The exercise is crucial to ensure that good representation and responses are obtained from the wide spectrum of stakeholders that JPND wishes to engage with.

JPND is asking individuals and organisations with an interest in neurodegenerative diseases to respond. Most respondees will find that the survey takes around 30 minutes to complete.

Please note that the consultation is in English and is structured so that people need only respond to the issues which interest them most.

The link to provide access is:http://bit.ly/jpnd2